MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clnesp.2026.102943

Медицинская библиотека · Clinical nutrition ESPEN · 2026

Prevalence and prognostic impact of malnutrition at cancer diagnosis: A prospective cohort study.

Hsu Yu-Wei, Lu Chang-Hsien, Chen Shih-Ying, Kou Hao-Wei, Chen Yi-Fu, Chen Ming-Yang, Hsu Jun-Te, Yeh Kun-Yun, Hung Yu-Shin, Chou Wen-Chi

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Malnutrition is a prevalent yet often under-recognized condition in oncology that could potentially compromise treatment outcomes. This study assessed its prevalence at cancer diagnosis and the prognostic implications within a large cohort of adult patients with cancer.

METHODS

In this prospective study, 2501 adults with newly diagnosed, histologically confirmed cancer (2018-2022) underwent nutritional screening within seven days preceding the initiation of cancer therapy. Nutritional status was assessed using the Mini Nutritional Assessment-Short Form and patients were classified as well-nourished (12-14), at-risk (8-11), or malnourished (<8) points. Overall survival was analyzed using Kaplan-Meier estimates and multivariable Cox models.

RESULTS

At baseline, 47.1 % of patients were at risk of malnutrition and 12.0 % were malnourished, together comprising 59.1 % of patients with compromised nutrition. The highest burden was observed in pancreatic (74.2 %), esophageal (72.8 %), and gastric (65.3 %) cancers. Malnourished patients more frequently presented with stage IV disease (62.7 % vs. 49.5 % in well-nourished patients; P < 0.001) and with poor performance status (ECOG ≥2: 20.0 % vs. 4.8 %, respectively; P < 0.001). Three-year overall survival was 69.8 % in well-nourished patients, 51.5 % in those at risk, and 37.2 % in malnourished patients (log-rank P < 0.001). Adjusted hazard ratios (HRs) for mortality were 1.79 (95 % confidence interval [CI], 1.51-2.13) in the at-risk group and 2.74 (95 % CI, 2.20-3.42) in the malnourished group. Exploratory site-specific analyses suggested heterogeneity in the association between nutritional status and survival across tumor types.

CONCLUSION

Pre-treatment MNA-SF screening identifies patients with cancer who are at high risk of mortality. Prospective trials are needed to determine whether nutritional interventions can improve survival outcomes, particularly in patients with gastrointestinal and head and neck cancers.

Для цитирования: Hsu Yu-Wei, Lu Chang-Hsien, Chen Shih-Ying, Kou Hao-Wei, Chen Yi-Fu, Chen Ming-Yang, Hsu Jun-Te, Yeh Kun-Yun, Hung Yu-Shin, Chou Wen-Chi. Prevalence and prognostic impact of malnutrition at cancer diagnosis: A prospective cohort study.. Clinical nutrition ESPEN. 2026. DOI: 10.1016/j.clnesp.2026.102943.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.